Stock Movers: RocketLab Rises on Space Interest; Moderna Moves on Flu Shot

Stock markets are responding positively to recent corporate developments across multiple sectors. RocketLab's shares are climbing following strong earnings from competitor SpaceX, while Moderna gains momentum after FDA approval of its mRNA flu vaccine. Intel is also capitalizing on investor enthusiasm by planning a $15 billion common stock offering to fund expansion during the AI data center boom.